| BDKRB2 |
BDKRB2, BKR2: B2 bradykinin receptor |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
0.347 |
Evidence |
|
| BDKRB2 |
BDKRB2, BKR2: B2 bradykinin receptor |
GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
0.347 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
OXTR |
OXTR: Oxytocin receptor |
0.347 |
Evidence |
|
| EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
0.347 |
Evidence |
|
| DPP4 |
DPP4, ADCP2, CD26: Dipeptidyl peptidase 4 |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.347 |
Evidence |
|
| FGFR4 |
FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.347 |
Evidence |
|
| FGFR4 |
FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
0.347 |
Evidence |
|
| CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
OXTR |
OXTR: Oxytocin receptor |
0.347 |
Evidence |
|
| CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
BDKRB2 |
BDKRB2, BKR2: B2 bradykinin receptor |
0.347 |
Evidence |
|
| EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
0.347 |
Evidence |
|
| EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
0.347 |
Evidence |
|
| GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
AVPR1B |
AVPR1B, AVPR3, VPR3: Vasopressin V1b receptor |
0.347 |
Evidence |
|
| GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
AVPR1B |
AVPR1B, AVPR3, VPR3: Vasopressin V1b receptor |
0.347 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
0.347 |
Evidence |
|
| CAPN2 |
CAPN2, CANPL2: Calpain-2 catalytic subunit precursor |
CST5 |
CST5: Cystatin-D precursor |
0.347 |
Evidence |
|
| CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
AVPR1B |
AVPR1B, AVPR3, VPR3: Vasopressin V1b receptor |
0.347 |
Evidence |
|
| CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
0.347 |
Evidence |
|
| CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
AVPR1A |
AVPR1A, AVPR1: Vasopressin V1a receptor |
0.347 |
Evidence |
|
| CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
OXTR |
OXTR: Oxytocin receptor |
0.347 |
Evidence |
|
| CCL4 |
CCL4, CCL4L, LAG1, MIP1B, SCYA4, SCYA4L: Small-inducible cytokine A4 precursor |
AVPR1A |
AVPR1A, AVPR1: Vasopressin V1a receptor |
0.347 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
BDKRB2 |
BDKRB2, BKR2: B2 bradykinin receptor |
0.347 |
Evidence |
|
| PF4V1 |
PF4V1, SCYB4V1: Platelet factor 4 variant precursor |
AVPR1B |
AVPR1B, AVPR3, VPR3: Vasopressin V1b receptor |
0.347 |
Evidence |
|
| PF4V1 |
PF4V1, SCYB4V1: Platelet factor 4 variant precursor |
OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
0.347 |
Evidence |
|
| PF4V1 |
PF4V1, SCYB4V1: Platelet factor 4 variant precursor |
BDKRB2 |
BDKRB2, BKR2: B2 bradykinin receptor |
0.347 |
Evidence |
|
| IL8 |
IL8: Interleukin-8 precursor |
AVPR1A |
AVPR1A, AVPR1: Vasopressin V1a receptor |
0.347 |
Evidence |
|